comparemela.com

Latest Breaking News On - Systolic blood pressure - Page 8 : comparemela.com

Personalized mindfulness program helps lower blood pressure and improve treatment outcome: AHA

Cureus | A Systematic Review Exploring the Cardiovascular and Renal Effects of Empagliflozin in Patients With Heart Failure With Reduced Ejection Fraction

The major cause of death in the United States is heart disease. The global burden of illness and mortality from heart failure is substantial. Despite recent innovations in the treatment of heart failure, the prognosis is still poor. To identify, evaluate, and summarize the findings of all relevant studies of a drug that is equally efficacious but rather cost-effective, empagliflozin compared to the other sodium-glucose cotransporter-2 (SGLT2) inhibitors was studied. It is licensed by the Food and Drug Administration (FDA), acts by preventing the reabsorption of glucose from the kidney, and exhibits promising advantages in heart failure. We systematically explored PubMed, PubMed Central (PMC), and Medical Literature Analysis and Retrieval System Online (MEDLINE) for randomized controlled trials (RCTs) and observational studies related to cardiovascular and renal outcomes of empagliflozin in patients with heart failure with reduced ejection fraction (HFrEF). After performing scoping se

Dr Ackaah-Gyasi bemoan prevalence of hypertension in Ghana

Dr Ekow Mensah Ackaah-Gyasi, a Senior House Officer, Obstetrics and Gynecology Department at the Effia-Nkwanta Regional Hospital (ENRH), has expressed concern that the prevalence of hypertension in Ghana is still high. He noted that the gap in hypertension prevalence between rural and urban populations is closing, especially among the elderly…

Hypertension in Ghana still high – Dr Ackaah-Gyasi bemoans

Hypertension in Ghana still high – Dr Ackaah-Gyasi bemoans
modernghana.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernghana.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.